Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bokemeyer

Showing results (61-70 of 333) with videos related to

Pageof 34
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2015
The impact of social factors on outcomes in patients with bleeding disordersK Holstein, S von Mackensen, C Bokemeyer, et al.
International Journal of Cancer|December 22, 1999
Therapy-related malignancies following treatment of germ cell cancerC Kollmannsberger, J T Hartmann, L Kanz, et al.
Journal of Cancer Research and Clinical Oncology|June 10, 1998
Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignanciesC Kollmannsberger, J T Hartmann, L Kanz, et al.
World Journal of Urology|January 1, 1994
Treatment intensification in disseminated germ-cell tumorsJ Beyer, C Bokemeyer, H J Schmoll, et al.
Der Urologe. Ausg. A|June 29, 2021
[Diagnosis and treatment of rare testicular tumors using the example of malignant mesothelioma of the tunica vaginalis testis and Sertoli cell tumors]G von Amsberg, M Sehovic, M Hartmann, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Targeting of neoglycoprotein-drug conjugates to cultured human embryonal carcinoma cellsH J Gabius, C Bokemeyer, T Hellmann, et al.
Oncology|January 14, 1999
Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experienceC Kollmannsberger, K Mross, A Jakob, et al.
Current Opinion in Urology|September 27, 2000
Sexual function and fertility after treatment of testicular cancerM Kuczyk, S Machtens, C Bokemeyer, et al.
British Journal of Cancer|May 1, 1996
Endocrinological late effects after chemotherapy for testicular cancerC C Berger, C Bokemeyer, F Schuppert, et al.
Hamostaseologie|September 11, 2012
Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisoloneK Holstein, G Marx, B Lentz, et al.
Pageof 34

Showing results (61-70 of 333) with videos related to

Sort By:
Pageof 34
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2015
The impact of social factors on outcomes in patients with bleeding disordersK Holstein, S von Mackensen, C Bokemeyer, et al.
International Journal of Cancer|December 22, 1999
Therapy-related malignancies following treatment of germ cell cancerC Kollmannsberger, J T Hartmann, L Kanz, et al.
Journal of Cancer Research and Clinical Oncology|June 10, 1998
Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignanciesC Kollmannsberger, J T Hartmann, L Kanz, et al.
World Journal of Urology|January 1, 1994
Treatment intensification in disseminated germ-cell tumorsJ Beyer, C Bokemeyer, H J Schmoll, et al.
Der Urologe. Ausg. A|June 29, 2021
[Diagnosis and treatment of rare testicular tumors using the example of malignant mesothelioma of the tunica vaginalis testis and Sertoli cell tumors]G von Amsberg, M Sehovic, M Hartmann, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Targeting of neoglycoprotein-drug conjugates to cultured human embryonal carcinoma cellsH J Gabius, C Bokemeyer, T Hellmann, et al.
Oncology|January 14, 1999
Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experienceC Kollmannsberger, K Mross, A Jakob, et al.
Current Opinion in Urology|September 27, 2000
Sexual function and fertility after treatment of testicular cancerM Kuczyk, S Machtens, C Bokemeyer, et al.
British Journal of Cancer|May 1, 1996
Endocrinological late effects after chemotherapy for testicular cancerC C Berger, C Bokemeyer, F Schuppert, et al.
Hamostaseologie|September 11, 2012
Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisoloneK Holstein, G Marx, B Lentz, et al.
Pageof 34